http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9013284-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0ef049605214ab2d6cbb74d055c351e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
filingDate 1990-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a93aac05ec5d170380029d69dd8d35e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48eb9ade56bcad413fcbdb2a91853670
publicationDate 1990-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9013284-A1
titleOfInvention Pharmaceutical composition containing sodium cromoglycate
abstract A pharmaceutical solution comprising 0.1 to 6.0 % w/w sodium cromoglycate, 0.1 to 2.0 % w/w carbomer, and sufficient quantity of an inorganic base to confer on the solution a pH of from 5.0 to 6.8, the solution containing no amino acids possesses advantageous properties, particularly for ophthalmic use. The solution preferably contains less than 1.5 %, more preferably less than 1.0 %, and more than 0.6 %, e.g. about 0.8 % w/w carbomer. The solution preferably contains more than 1.0 %, e.g. 2 % w/w, and more preferably more than 3 %, e.g. 4 % w/w, of sodium cromoglycate. The concentration of sodium cromoglycate in the solution is preferably less than 5 % w/w. The preferred inorganic base is sodium hydroxide at a concentration of 0.15 to 0.3 % w/w. Also described are processes for the preparation of the solution and methods of treatment involving its use.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6596284-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2549472-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-1005196-A0
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2262448-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2686513-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9300887-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2860718-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2678832-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0587264-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2262448-B
priorityDate 1989-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61106509-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0275054-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63101318-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13020083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410876
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11287299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129753389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819

Total number of triples: 41.